CARDIOVASCULAR JOURNAL OF AFRICA • Vol 21, No 5, September/October 2010
284
AFRICA
enhances the hemodynamic effects of felodipine
.
Clin Invest Med
1989;
12
(6): 357–362.
16. Pillai U, Muzaffar J, Sen S, Yancey A. Grapefruit juice and verapamil: a
toxic cocktail.
South Med J
2009;
102
: 308–309.
17. Bailey DG, Arnold JMO, Strong HA, Munoz C, Spence JD. Effect of
grapefruit juice and naringin on nisoldipine pharmacokinetics.
Clin
Pharm Ther
1993;
54
: 589–594.
18. Fuhr U, Maier-Brüggemann A, Blume H, Mück W, Unger S, Kuhlmann
J,
et al
. Grapefruit juice increases oral nimlodipine bioavailability.
Int J
Clin Pharmacol Ther
1998;
36
: 126–132.
19. Odou P, Ferrari N, Barthélémy C, Brique S, Lhermitte M, Vincent A,
et al
. Grapefruit juice–nifedipine interaction: possible involvement of
several mechanisms.
J Clin Pharm Ther
2005;
30
(2): 153–158.
20. Josefsson M, Zackrisson AL, Ahlner J. Effect of grapefruit juice on
the pharmacokinetics of amlodipine in healthy volunteers.
Eur J Clin
Pharmacol
1996;
51
: 189–193.
21. Vincent J, Harris SI, Foulds G, Dogolo LC, Willavize S, Friedman HL.
Lack of effect of grapefruit juice on the pharmacokinetics and hemody-
namics of amlodipine.
Br J Clin Pharmacol
2000;
50
: 455–463.
22. Guo LQ, Fukuda K, Ohta T, Yamazoe Y. Role of furanocoumarin deriva-
tives in grapefruit juice-mediated inhibition of human CYP3A4 activity.
Drug Metab Dispos
2000;
28
: 766–771.
23. Kakar SM, Paine MF, Stewart PW, Watkins PB. 6
′
,7
′
-dihydroxyberga-
mottin contributes to the grapefruit effect.
Clin Pharmacol Ther
2004;
75
: 569–579.
24. Goosen TC, Cillié D, Bailey DG, Yu C, He K, Hollenberg PF,
et al
.
Bergamottin contribution to the grapefruit juice-felodipine interaction
and disposition in humans.
Clin Pharmacol Ther
2004;
76
(6): 607–617.
25. Lown KS, Bailey DG, Fontana RJ, Janardan SK, Adair CH, Fortlage
LA,
et al
. Grapefruit increases felodipine oral bioavailability in humans
by decreasing intestinal CYP3A protein expression.
J Clin Invest
1997;
99
: 2545–2553.
26. MiniscalcoA, Lundahl J, Regardh CG, Edgar B, Eriksson UG. Inhibition
of dihydropyridine metabolism in rat and human liver microsomes by
flavonoids found in grapefruit juice.
Pharmacol Exp Ther
1992;
261
(3):
1195–1199.
27. Tassaneeyakul W, Guo LQ, Fukuda K, Ohta T, Yamazoe Y. Inhibition
selectivity of grapefruit juice components on human cytochromes P450.
Arch Biochem Biophys
2000;
387
(2): 356–363.
28. Mays DC, Hilliard JB, Wong DD, Chambers MA, Park SS, Gelboin HV,
Gerber N. Bioactivation of 8-methoxypsoralen and irreversible inactiva-
tion of cytochrome P-450 in mouse liver microsomes: modification by
monoclonal antibodies, inhibition of drug metabolism and distribution
of covalent adducts.
J Pharmacol Exp Ther
1990;
254
: 720–731.
29. Murray GI, Taylor MC, McFadyen MCE, McKay JA, Greenlee WF,
Burke MD, Melvin WT. Tumor-specific expression of cytochrome P450
CYP1B1.
Cancer Res
1997;
57
: 3026–3031.
30. Rashid TJ, Martin U, Clarke H, Waller DG, Renwick AG, George CF.
Factors affecting the absolute bioavailability of nifedipine.
Br J Clin
Pharmacol
1995;
40
: 51–58.
31. Hsiang B, Zhu Y, Wang Z, Wu Y, Sasseville V, Yang WP, Kirchgessner
TG. A novel human hepatic organic anion transporting polypeptide
(OATP2). Identification of a liver-specific human organic anion trans-
porting polypeptide and identification of rat and human hydroxymeth-
ylglutaryl-CoA reductase inhibitor transporters.
J Biol Chem
1999;
274
:
37161–37168.
32. Kivisto KT, Niemi M, Fromm MF. Functional interaction of intestinal
CYP3A4 and P-glycoprotein.
Fund Clin Pharmacol
2004;
18
: 621-629.
33. Marzolini C, Paus E, Buclin, Kim RB. Polymorphisms in human MDR1
(P-glycoprotein): recent advances and clinical relevance.
Clin Pharmcol
Ther
2004;
75
: 13–33.
34. De Castro WV, Mertens-Talcott S, Derendorf H, Butterweck V.
Grapefruit juice–drug interactions: grapefruit juice and its components
inhibit P-glycoprotein (ABC1) mediated transport of talinolol in Caco-2
cells.
J Pharmaceut Sci
2007;
96
: 2808–2817.
35. Shirasaka Y, Li Y, Shibue Y, Kuraoka E, Spahn-Langguth H, Kato Y,
et
al
. Concentration-dependent effect of naringin on intestinal absorption
of beta(1)-adrenoceptor antagonist talinolol mediated by p-glycoprotein
and organic anion transporting polypeptide (Oatp).
Pharma Res
2009;
26
(3): 560.
36. Becquemont L, Verstuyft C, Kerb R, Brinkmann U, Lebot M, Patrice
Jaillon P,
et al
. Effect of grapefruit juice on digoxin pharmacokinetics in
humans.
Clin Pharmacol Ther
2001;
70
: 311–316.
37. Mooradian AD. Digitalis: An update of clinical pharmacokinetics,
therapeutic monitoring techniques and treatment recommendation.
Clin
Pharmacokinet
1988;
15
: 165–179.
38. Dresser GK, Bailey DG. The effects of fruit juices on drug disposition:
a new model for drug interactions.
Eur J Clin Invest
2003;
33
:(suppl
2): 10–16.
39. Zaidenstein R, Soback S, Gips M, Avni B, Dishi V, Weissgarten Y,
et al
.
Effect of grapefruit juice on the pharmacokinetics of losartan and its
active metabolite E3174 in healthy volunteers.
Ther Drug Monit
2001;
23
(4): 369–373.
40. Bailey DG, Dresser GK. Interaction between grapefruit juice and cardio-
vascular drugs.
Am J Cardiovasc Drugs
2004;
4
: 281–297.
41. Libersa CC, Brique SA, Motte KB, Caron JF, Guédon-Moreau LM, Luc
Humbert L,
et al
. Dramatic amiodarone metabolism induced by grape-
fruit juice.
Br J Clin Pharmacol
2000;
49
: 373–337.
42. Le Goff-Klein N, Koffel JC, Jung L, Ubeaud G.
In vitro
inhibition of
simvastatin metabolism, a HMG-CoA reductase inhibitor in human and
rat liver by bergamottin, a component of grapefruit juice.
Eur J Pharm
Sci
2003;
18
: 31–35.
43. Lilja JJ, Neuvonen M, Neuvonen PJ. Effects of regular consumption
of grapefruit juice on the pharmacokinetics of simvastatin.
Br J Clin
Pharmacol
2004;
58
(1): 56–60.
44. Lilja JJ, Kivisto KT, Neuvonen PJ. Grapefruit juice increases serum
concentrations of atorvastatin and has no effect on pravastatin.
Clin
Pharmacol Ther
1999;
66
(2): 118–127.
45. Greenblatt DJ, Patki KC, von Moltke LL, Shader RI. Drug interactions
with grapefruit juice: an update.
J Clin Pyschopharmacol
2001;
21
:
357–359.
46. Tomilson B, Chow MSS. Stereoselective interaction of manidipine and
grapefruit juice: a new twist on an old tale.
Br J Clin Pharmacol
2006;
61
(5): 529–532.
47. Lundahl J, Regårdh CG, Edgar B, Johnsson G. Effects of grapefruit
juice ingestion-pharmacokinetics and haemodynamics of intravenously
administered felodipine in healthy men.
Eur J Clin Pharmacol
1997;
52
(2): 139–145.
48. Bailey DG, Dresser GK. Interaction between grapefruit juice and cardio-
vascular drugs.
Am J Cardiovasc Drugs
2004;
4
: 281–297.
49. Lilja JJ, Kivisto KT, Neuvonen PJ. Grapefruit juice-simvastatin interac-
tion: effect on serum concentrations of simvastatin, simvastatin acid,
and HMG-Co A reductase inhibitors.
Clin Pharmacol Ther
1998;
64
:
477–483.
50. Kantola T, Kivisto KT, Neuvonen PJ. Grapefruit greatly increases serum
concentrations of lovastatin and lovastatin acid.
Clin Pharmacol Ther
1998;
63
: 397–402.
51. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake
DB,
et al
. Implications of recent clinical trials for National Cholesterol
Education Programme Adult Treatment Panel II guidelines.
Circulation
2004;
110
: 227–239.
52. Taniguchi K, Ohtani H, Ikemoto T, Miki A, Hori S, Sawada Y. Possible
case of potentiation of the antiplatelet effect of cilostazol by grapefruit
juice.
J Clin Pharm Therapeut
2007;
32
: 457–459.
53. Bressier R, Bahl JJ. Principles of drug therapy for the elderly patient.
Mayo Clin Proc
2003;
78
(12): 1564–1577.
54. Clotz U. Effect of age on pharmacokinetics and pharmacodynamics in
man.
Int J Clin Pharmacol Ther
1998;
36
(11): 581–585.
55. Row E, Brown SA, Stachulski AV, Lennard MS. Development of novel
furanocoumarin dimmers as potent and selective inhibitors of CYP3A4.
Drug Metab Dispos
2006;
34
(2): 324–330.
56. Oda K, Yamaguchi Y, Yoshimura T, Wada K, Nishizono N. Synthetic
models related to the furnanocoumarin, coumarin, and benzofuran
dimers as potent and selective inhibitors of CYP3A4 activity.
Chem
Pharm Bull
2007;
59
(9): 1419–1421.
57. Paine MF, Widmer WW, Hart HL, Pusek SN, Beavers KL, Criss AB,
et
al
. A furanocoumarin-free grapefruit juice establishes furanocourmarins
as the selective mediators of the grapefruit juice-felodipine interaction.
